Transcriptome changes during peanut oral immunotherapy and omalizumab treatment

Peanut allergy is a common food allergy and the main cause of anaphylaxis among children . In recent years, oral immunotherapy has emerged as a promising treatment for children with different IgE-mediated food allergies, although safety issues must be considered . The main aim of immunotherapy is to induce tolerance or desensitization to an allergen which otherwise causes an allergic reaction. For oral immunotherapy this means ingesting the allergen in a controlled manner with gradually increasing dosages.